Core Insights - Keurig Dr Pepper Inc. (KDP) is expected to report fourth-quarter 2025 results on February 24, with projected revenue of $4.36 billion, reflecting a 7.2% increase year-over-year [1][9] - The consensus estimate for KDP's earnings per share (EPS) remains at 59 cents, indicating a 1.7% year-over-year growth [2] Financial Performance - KDP's Refreshment Beverages segment is projected to generate $2.7 billion in revenue, a 12.5% increase from the previous year, driven by pricing and volume gains [5][9] - The company has achieved an average earnings surprise of 3.1% over the last four quarters, with the last quarter showing a break-even earnings surprise [2] Growth Drivers - Continued strength in brand performance, pricing actions, and expansion initiatives are contributing positively to KDP's results [3][4] - The company is focusing on premium and cold coffee innovations, along with partnerships to enhance its product portfolio [4] Challenges - KDP faces challenges from tariff and inflationary pressures, particularly in green coffee prices, and has been experiencing a sluggish performance in its Coffee segment [6][9] - Elevated selling, general and administrative (SG&A) costs, including increased marketing investments, are also impacting profitability [6] Valuation - KDP's stock is currently trading at a forward price-to-earnings ratio of 13.25x, which is below its five-year high of 23.33x and the industry average of 20.08x, indicating potential value for investors [7] Market Performance - KDP's shares have increased by 8.4% over the past three months, compared to the industry's growth of 12.5% [8]

Core Insights - TPG RE Finance Trust reported revenue of $35.04 million for Q4 2025, marking a year-over-year increase of 0.9% and an EPS of $0.24 compared to $0.10 a year ago, but fell short of the Zacks Consensus Estimate by 8.42% [1] - The EPS also missed the consensus estimate of $0.27 by 10.01% [1] Financial Performance Metrics - Net Interest Income was reported at $25.44 million, below the estimated $28.49 million [4] - Revenue from real estate owned operations was $7.79 million, slightly above the average estimate of $7.53 million [4] - Other income, net, was $1.81 million, falling short of the $2.25 million average estimate [4] - Total other revenue reached $9.6 million, compared to the average estimate of $9.78 million [4] Stock Performance - TPG RE Finance Trust shares have returned -3.9% over the past month, underperforming the Zacks S&P 500 composite, which changed by -1.4% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]

Core Insights - Lockheed Martin Corporation (LMT) is valued at a market cap of $150.1 billion and specializes in aerospace and defense technology systems [1] Performance Overview - LMT shares have surged 50.1% over the past 52 weeks, significantly outperforming the S&P 500 Index, which gained 11.8% during the same period [2] - Year-to-date, LMT stock is up 34.9%, while the S&P 500 Index has experienced a slight decline [2] - Compared to the iShares U.S. Aerospace & Defense ETF (ITA), which increased by 51.5% over the past 52 weeks, LMT has lagged but outperformed ITA's 9.4% year-to-date rise [3] Financial Performance - On January 29, LMT's shares rose 4.2% following stronger-than-expected Q4 results, with total sales increasing by 9.1% year-over-year to $20.3 billion, exceeding consensus estimates by 2.5% [4] - The company's net income per share saw a remarkable increase of 161.3% from the previous year, reaching $5.80 [4] Future Earnings Expectations - Analysts project LMT's EPS to grow by 4.5% year-over-year to $29.81 for fiscal 2026 [5] - LMT has a strong earnings surprise history, having exceeded consensus estimates in each of the last four quarters [5] Analyst Ratings - Among 23 analysts covering LMT, the consensus rating is a "Moderate Buy," consisting of seven "Strong Buy," 15 "Hold," and one "Strong Sell" ratings [5] - As of February 5, BofA maintained a "Neutral" rating on LMT and raised its price target to $660, indicating a potential upside of 1.1% from current levels [7] - LMT is currently trading above its mean price target of $624.05, with a Street-high price target of $695 suggesting a potential upside of 6.5% [7]

Company Overview - Paychex, Inc. (PAYX) has a market capitalization of $33.9 billion and is a leading provider of human capital management (HCM) solutions, offering services such as payroll, HR, employee benefits, and insurance to small and medium-sized businesses in the U.S., Europe, and India [1] Stock Performance - Over the past 52 weeks, PAYX shares have decreased by 36.5%, while the S&P 500 Index has increased by 11.8% [2] - Year-to-date, PAYX shares are down 15.9%, contrasting with a slight decline in the S&P 500 [2] - PAYX has underperformed the State Street Industrial Select Sector SPDR ETF, which has returned 26.3% over the same period [3] Financial Results - For Q2 2026, Paychex reported adjusted EPS of $1.26 and revenue of $1.56 billion, reflecting an 18% year-over-year increase, both exceeding forecasts [5] - Adjusted operating income grew by 21% to $649 million, supported by a 17% contribution from the Paycor acquisition to Management Solutions revenue growth [5] - The company raised its full-year fiscal 2026 outlook, projecting a 10% - 11% growth in adjusted EPS [5] Analyst Expectations - Analysts forecast a 9.2% year-over-year growth in PAYX's adjusted EPS for the fiscal year ending in May 2026, reaching $5.44 [6] - PAYX has a positive earnings surprise history, having exceeded consensus estimates in the last four quarters [6] - The consensus rating among 18 analysts is a "Hold," with 14 "Hold" ratings and four "Strong Sells" [6] Price Targets - Kevin McVeigh of UBS maintains a "Hold" rating on Paychex with a price target of $110 [8] - The mean price target of $122.07 indicates a 29.3% premium to current price levels, while the highest price target of $150 suggests a potential upside of 58.9% [8]

Core Insights - UnitedHealth Group Incorporated (UNH) has a market capitalization of $265.6 billion and operates organized health systems, providing employee benefit programs globally [1] Performance Overview - UNH shares have underperformed the broader market, declining 44.8% over the past year, while the S&P 500 Index has increased by nearly 11.8% [2] - In 2026, UNH's stock fell 11.2%, contrasting with a slight dip in the S&P 500 on a year-to-date basis [2] - Compared to the iShares U.S. Healthcare Providers ETF (IHF), which declined about 12.1% over the past year and 3.5% year-to-date, UNH's underperformance is evident [3] Financial Results - On January 27, UNH shares dropped 19.6% following the release of fiscal 2025 Q4 results, where revenue increased by 12.3% year-over-year to $113.22 billion, driven by growth in Optum and enrollment in UnitedHealthcare's government programs, but slightly below consensus expectations [5] - Adjusted EPS was approximately $2.11, meeting expectations, but underlying profitability weakened due to high medical utilization and care costs compressing insurance margins, particularly in Medicare Advantage [5] - The company incurred $1.6 billion in charges related to Optum portfolio realignment and business optimization, impacting reported earnings and segment margins [5] Analyst Expectations - For the current fiscal year ending in December, analysts project UNH's EPS to rise by 8.2% to $17.69 on a diluted basis [6] - UNH has a mixed earnings surprise history, beating consensus estimates in two of the last four quarters while missing forecasts in two others [6] - Among 26 analysts covering UNH stock, the consensus rating is a "Moderate Buy," with 16 "Strong Buy" ratings, two "Moderate Buys," seven "Holds," and one "Strong Sell" [6] - The analyst configuration has become more bullish, with 15 analysts now suggesting a "Strong Buy" [7]

Core Insights - Automatic Data Processing, Inc. (ADP) has a market capitalization of $87.6 billion and specializes in cloud-based human capital management (HCM) solutions [1] - Over the past 52 weeks, ADP's shares have declined by 29.5%, significantly underperforming the S&P 500 Index, which gained 14.4% during the same period [1] - Year-to-date, ADP's stock is down 16%, while the S&P 500 has returned 1.4% [1] Financial Performance - In Q2, ADP's total revenue increased by 6.2% year-over-year to $5.4 billion, but this figure slightly missed Wall Street expectations [4] - The adjusted EPS for the same quarter rose by 11.5% to $2.62, surpassing consensus estimates of $2.58 [4] - For fiscal 2026, analysts project ADP's EPS to grow by 9.5% year-over-year to $10.96 [5] Analyst Ratings and Price Targets - Among 18 analysts covering ADP, the consensus rating is a "Hold," with three "Strong Buy," 12 "Hold," one "Moderate Sell," and two "Strong Sell" ratings [5] - The mean price target for ADP is $281.40, indicating a 32% premium to its current price, while the highest target of $332 suggests a potential upside of 55.7% [7] - Stifel Financial Corp. analyst David Grossman maintained a "Hold" rating and lowered the price target to $270, indicating a 26.6% potential upside from current levels [6]

Core Viewpoint - Capital One Financial Corporation has shown underperformance compared to the broader market, with stock prices lagging behind major indices over the past year and facing challenges in profitability despite exceeding revenue forecasts [2][5]. Group 1: Company Overview - Capital One Financial Corporation is a Virginia-based bank holding company and diversified financial services provider, founded in 1994, and has become one of the largest consumer banks in the U.S. with a market cap of $139.8 billion [1]. - The company operates through three segments: Credit Card, Consumer Banking, and Commercial Banking [1]. Group 2: Stock Performance - Over the past 52 weeks, Capital One's stock prices have increased by 7.6%, while the S&P 500 Index has gained 14.4% [2]. - Year-to-date, Capital One shares have decreased by 11.5%, contrasting with the S&P 500's rise of 1.4% [2]. Group 3: Earnings Report - On January 22, Capital One's shares fell by 6.2% after the company reported Q4 2025 results that missed profit expectations, with adjusted EPS at $3.86, below the consensus estimate of $4.14 [5]. - The efficiency ratio rose to 60%, significantly higher than the projected 52.5%, indicating expense pressures [5]. - Revenue for the quarter was $15.58 billion, which modestly exceeded forecasts, but weaker profitability led to a negative market reaction [5]. Group 4: Future Expectations - Analysts expect Capital One to deliver an adjusted EPS of $20.21 for the current year, reflecting a 3.1% year-over-year increase [6]. - The company has a mixed earnings surprise history, surpassing bottom-line estimates in three of the past four quarters [6]. Group 5: Analyst Ratings - Among 23 analysts covering Capital One, the consensus rating is a "Strong Buy," consisting of 16 "Strong Buys," two "Moderate Buys," and five "Holds" [6]. - The configuration has become slightly bearish compared to three months ago, when 17 analysts recommended "Strong Buy" [7]. - Truist Securities recently cut its price target on Capital One to $275 from $290 while maintaining a "Buy" rating, citing elevated expenses and dilution from the Brex acquisition [7].

Core Viewpoint - Pentair plc has underperformed the broader market and industry benchmarks over the past year, with stock price gains significantly lagging behind the S&P 500 Index and the Invesco Global Water ETF [2][3]. Company Overview - Pentair plc is a global industrial company based in London, U.K., specializing in water treatment and fluid management solutions, with a market capitalization of $16.1 billion [1]. Financial Performance - In Q4 2025, Pentair reported a 5% increase in sales to $1 billion compared to approximately $973 million in Q4 2024, while adjusted earnings per share rose by 9% to $1.18 [5]. - Operating income for the quarter increased by about 5% to $205 million, with record free cash flow of $748.4 million [5]. - The company returned $225 million to shareholders through share repurchases [5]. Stock Performance - Over the past 52 weeks, Pentair's stock has gained nearly 1.3%, while the S&P 500 Index has increased by 14.4% [2]. - In 2026, Pentair's stock has declined by 3.5%, compared to a 1.4% rise in the S&P 500 [2]. Industry Comparison - Pentair has underperformed the Invesco Global Water ETF, which surged by 17.2% over the past 52 weeks and 9.1% year-to-date [3]. Analyst Expectations - For FY2026, analysts expect Pentair to achieve an adjusted EPS improvement of 8.5% year-over-year to $5.34 [6]. - The consensus rating among 21 analysts covering Pentair is a "Moderate Buy," with a mix of ratings including 12 "Strong Buys" and two "Strong Sells" [6]. Analyst Ratings - Citigroup analyst Andrew Kaplowitz maintained a "Buy" rating on Pentair but reduced the price target from $126 to $120, indicating a 4.76% decrease [7].

Core Viewpoint - American Water Works Company, Inc. (AWK) has shown underperformance compared to the broader market and specific water-related ETFs despite reporting stronger-than-expected earnings in Q3. Financial Performance - AWK reported Q3 operating revenue of $1.5 billion, a 9.7% increase year-over-year, exceeding consensus estimates by 9.8% [5] - Earnings per share (EPS) grew 7.8% from the previous year to $1.94, surpassing analyst expectations by 2.1% [5] - For the current fiscal year, analysts project AWK's EPS to grow 6.3% year-over-year to $5.73 [6] Market Comparison - Over the past 52 weeks, AWK shares have gained only 1.6%, while the S&P 500 Index has increased by 14.4% [2] - AWK has also underperformed the Invesco Global Water ETF (PIO), which rose 17.9% over the same period [3] Cost and Debt Concerns - Operating expenses increased by 7.3% year-over-year to $837 million, raising concerns among investors [5] - Total long-term debt rose by 4% to $13 billion [5] Analyst Ratings - Among 13 analysts covering AWK, the consensus rating is a "Hold," with two "Strong Buy," ten "Hold," and one "Strong Sell" ratings [6] - The configuration of analyst ratings has become less bullish compared to a month ago, with three analysts suggesting a "Strong Buy" [8] - Barclays PLC maintained a "Sell" rating on AWK with a price target of $122 [9]

Company Overview - Becton, Dickinson and Company (BDX) is based in Franklin Lakes, New Jersey, with a market capitalization of $48.9 billion, focusing on the development, manufacturing, and sale of medical supplies, devices, laboratory equipment, and diagnostic products for various healthcare sectors worldwide [1] Stock Performance - BDX shares have underperformed the broader market, declining 25.2% over the past 52 weeks and 11.5% year-to-date (YTD), while the S&P 500 Index has returned 14.4% over the past year and increased by 1.4% in 2026 [2] - The stock has also lagged behind the State Street Healthcare Select Sector SPDR ETF (XLV), which rose by 6.2% over the past 52 weeks [3] Earnings Report - Following the Q4 2025 earnings release on February 9, BDX shares fell by 1.3%. The company's revenue increased by 1.6% year-over-year to $5.3 billion, surpassing consensus estimates. Adjusted EPS was $2.91, beating estimates by 3.2%. However, life sciences revenue of $766 million fell significantly short of the consensus estimate of $1.3 billion [4] Future Earnings Expectations - For the fiscal year ending in September 2026, analysts project BDX's EPS to grow by 2.9% year-over-year to $14.82 on a diluted basis. The company has a strong earnings surprise history, having exceeded consensus estimates in each of the last four quarters [5] Analyst Ratings - Among 14 analysts covering BDX stock, the consensus rating is a "Moderate Buy," consisting of six "Strong Buy" ratings and eight "Holds." This rating configuration has become more bullish over the past month, with "Strong Buy" ratings increasing from four to six [6] Price Target - JP Morgan analyst Robert Marcus maintained a "Neutral" rating for BDX and lowered the price target from $190 to $175. The mean price target of $204 indicates an upside potential of 18.8% from current market prices, while the highest target of $232 suggests a potential rally of up to 35.1% [8]